XML 28 R16.htm IDEA: XBRL DOCUMENT
v3.26.1

Accounts receivable | 6 Months Ended
--- | ---
Jun. 30, 2026
Trade and other receivables [abstract] |
Accounts receivable | B.7. Accounts receivable Accounts receivable break down as follows:
(€ million) | June 30, 2026 | December 31, 2025
Gross value | 8,818 |  | 8,510 |
Allowances | (104) |  | (100) |
Carrying amount | 8,714 |  | 8,410 |
The impact of allowances against accounts receivable in the first half of 2026 was a net expense of €6 million (versus a net expense of €4 million for the first half of 2025). The table below shows the ageing profile of overdue accounts receivable, based on gross value:
(€ million) | Overdue accounts gross value | Overdue by <1 month | Overdue by 1-3 months | Overdue by 3-6 months | Overdue by 6-12 months | Overdue by > 12 months
June 30, 2026 | 522 |  | 183 |  | 127 |  | 142 |  | 27 |  | 43 |
December 31, 2025 | 468 |  | 184 |  | 134 |  | 71 |  | 27 |  | 52 |
Amounts overdue by more than one month relate mainly to public-sector customers. Some Sanofi subsidiaries have assigned receivables to factoring companies or banks without recourse. The amount of receivables that met the conditions described in Note B.8.6. to the consolidated financial statements for the year ended December 31, 2025 and hence were derecognized was €11 million as of June 30, 2026 (versus zero as of December 31, 2025). The residual guarantees relating to those transfers were immaterial as of June 30, 2026.

X
- References No definition available. + Details
Name: | ifrs-full_TradeAndOtherReceivablesAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of trade receivables. + References No definition available. + Details
Name: | sny_DisclosureOfTradeReceivablesTextBlock
Namespace Prefix: | sny_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration